Basel, Switzerland

Aeron C Hurt


 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Aeron C Hurt: Innovator in Influenza Prevention

Introduction

Aeron C Hurt is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicine, particularly in the prevention of influenza virus transmission. With a total of 2 patents, his work is recognized for its potential impact on public health.

Latest Patents

Hurt's latest patents focus on a compound and method for preventing the transmission of the influenza virus. The invention involves administering an effective amount of a compound to patients infected with the influenza virus, referred to as 'index patients'. The compound is designed to reduce the infectivity of the influenza virus, thereby minimizing the risk of triggering an influenza epidemic or pandemic. The method emphasizes the administration of the compound to at least 10% of all influenza-infected individuals within a city's or country's population.

Career Highlights

Throughout his career, Aeron C Hurt has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Hoffmann-La Roche Inc. and Shionogi Company Limited. His experience in these organizations has contributed to his expertise in developing innovative solutions for viral infections.

Collaborations

Hurt has collaborated with esteemed colleagues, including Takeshi Noshi and Takahiro Noda. These partnerships have likely enhanced his research and development efforts in the field of influenza prevention.

Conclusion

Aeron C Hurt's innovative work in the prevention of influenza transmission showcases his dedication to improving public health. His patents reflect a commitment to finding effective solutions to combat viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…